Who owns AMBRX BIOPHARMA INC?
- CUSIP Number: 641871108
Tip: Access positions for across all investors
Analyze quarterly positions in Ambrx Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ambrx Biopharma stock
Who bought or sold AMBRX BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Darwin Global Management | 17M | $238M | 100% | Dec 2023 |
|
| Cormorant Asset Management | 11M | $160M | 100% | Dec 2023 |
|
| Paradigm Biocapital Advisors | 4.5M | $64M | 100% | Dec 2023 |
|
| D. E. Shaw & Co | 4.2M | $60M | 100% | Dec 2023 |
|
| Nextech Invest | 3.1M | $45M | 100% | Dec 2023 |
|
| Balyasny Asset Management | 2.2M | $31M | 100% | Dec 2023 |
|
| Citadel Advisors | 2.1M | $31M | 100% | Dec 2023 |
|
| Logos Global Management | 2.1M | $30M | 100% | Dec 2023 |
|
| VR Adviser | 2.1M | $30M | 100% | Dec 2023 |
|
| Vanguard Group | 1.4M | $20M | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 1.1M | $15M | 100% | Dec 2023 |
|
| WuXi AppTec | 1.0M | $14M | 100% | Dec 2023 |
|
| Millennium Management | 433k | $6.2M | 100% | Dec 2023 |
|
| Goldman Sachs Group | 400k | $5.7M | 100% | Dec 2023 |
|
| Federated Investors | 331k | $4.7M | 100% | Dec 2023 |
|
| OrbiMed Advisors | 296k | $4.2M | 100% | Dec 2023 |
|
| Jane Street | 296k | $4.2M | 100% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 264k | $3.8M | 100% | Dec 2023 |
|
| Alliancebernstein | 258k | $3.7M | 100% | Dec 2023 |
|
| Monashee Investment Management | 208k | $3.0M | 100% | Dec 2023 |
|
| Barclays | 200k | $2.8M | 100% | Dec 2023 |
|
| TD Asset Management | 140k | $2.0M | 100% | Dec 2023 |
|
| Perceptive Advisors | 79k | $1.1M | 100% | Dec 2023 |
|
| Royal Bank of Canada | 70k | $998k | 100% | Dec 2023 |
|
| NWI Management | 54k | $764k | 100% | Dec 2023 |
|
| Altitude Crest Partners | 43k | $614k | 100% | Dec 2023 |
|
| Sierra Summit Advisors | 37k | $530k | 100% | Dec 2023 |
|
| Bank of America Corporation | 37k | $523k | 100% | Dec 2023 |
|
| Fred Alger Management | 33k | $468k | 100% | Dec 2023 |
|
| Virtu Financial | 20k | $290k | 100% | Dec 2023 |
|
| Gts Securities | 19k | $269k | 100% | Dec 2023 |
|
| Citigroup | 19k | $267k | 100% | Dec 2023 |
|
| Bayesian Capital Management | 16k | $225k | 100% | Dec 2023 |
|
| Squarepoint Ops | 16k | $220k | 100% | Dec 2023 |
|
| Old Well Partners | 14k | $205k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 12k | $175k | 100% | Dec 2023 |
|
| Tudor Investment Corporation | 11k | $154k | 100% | Dec 2023 |
|
| Mirabella Financial Services | 10k | $143k | 100% | Dec 2023 |
|
| Virtus ETF Advisers | 6.9k | $98k | 100% | Dec 2023 |
|
| UBS Group | 3.8k | $55k | 100% | Dec 2023 |
|
| Us Bancorp | 906.00 | $13k | 100% | Dec 2023 |
|
| Daiwa Securities Group | 258.00 | $4.0k | 100% | Dec 2023 |
|
Who sold out of Ambrx Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| HealthInvest Partners AB | Dec 2023 | 58k | $824k |
| Simplex Trading | Dec 2023 | 7.7k | $109k |
| China Universal Asset Management | Dec 2023 | 7.3k | $104k |
| Cutler | Dec 2023 | 2.8k | $39k |
| GAMMA Investing | Dec 2023 | 491.00 | $14k |